The primary issue is management quality and execution. The company failed to build for scale. There are no clear or consistent processes, no real investment in cultivating mid level management, and no operational foundation that would allow teams to grow, standardize, or execute predictably.
Several senior leaders left, further weakening leadership depth and strategic direction.
Sales execution is deeply flawed. Commercial decision making lacked consistency and transparency, which eroded trust within the team and made it difficult to build a repeatable, performance driven sales culture. Sales enablement was insufficient, leaving representatives without the tools, training, or clarity needed to properly understand and position a complex technical product. Despite multiple organizational changes, results did not materially improve and turnover remained high.
There is no clear career path within the sales organization. No meaningful promotions occurred for SDRs or AEs, and compensation is average at best given the level of pressure, instability, and risk.
Despite raising a large funding round, the company did not demonstrate meaningful growth. Capital was often directed toward optics rather than toward strengthening product market fit, customer adoption, sales enablement, and go to market fundamentals.
The product struggles to compete in enterprise environments. Recent investments labeled as AI lack meaningful differentiation compared to standard market offerings.
Top management appears aware of many of these issues but does not intervene decisively in the execution of the rest of the executive team. Necessary leadership changes are delayed or avoided, allowing dysfunction to persist.
